The role of ADAM8 in KRAS 12/13-mutant CRC tumors, SEMA7A in BRAF-mutant CRC tumors, and ADAMTS10 in PIK3CA-mutated tumors requires further investigation. Here, ADAM8 is linked to colorectal carcinoma.